| [1] |
Coussens LM, Werb Z.Inflammation and cancer[J]. Nature, 2002, 420(6917):860-867.
|
| [2] |
Mantovani A.Cancer: inflammation by remote control[J]. Nature, 2005, 435(7043):752-753.
|
| [3] |
Correale C, Genua M, Vetrano S, et al.Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response[J]. Gastroenterology, 2013, 144(2):346-356.
|
| [4] |
Solinas G, Germano G, Mantovani A, et al.Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation[J]. J Leukoc Biol, 2009, 86(5):1065-1073.
|
| [5] |
Ho CC, Liao WY, Wang CY, et al.TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer[J]. Am J Respir Crit Care Med, 2008, 177(7):763-770.
|
| [6] |
Sigalov AB.A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopoly-saccharide-induced septic shock[J]. Int Immunopharmacol, 2014, 21(1):208-219.
|
| [7] |
Karapanagiotou EM, Pelekanou E, Charpidou A, et al.Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies[J]. Anticancer Res, 2008, 28(2B):1411-1415.
|
| [8] |
Yao Y, Li H, Chen J, et al.TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 depen-dent manner in lung cancer[J]. Oncotarget, 2016, 7(20):29620-29634.
|
| [9] |
Wu J, Li J, Salcedo R, et al.The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma[J]. Cancer Res, 2012, 72(16):3977-3986.
|
| [10] |
Liao R, Sun TW, Yi Y, et al.Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma[J]. Cancer Sci, 2012, 103(6):984-992.
|
| [11] |
Duan M, Wang ZC, Wang XY, et al.TREM-1, an inflam-matory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression[J]. Ann Surg Oncol, 2015, 22(9):3121-3129.
|
| [12] |
Schenk M, Bouchon A, Seibold F, et al.TREM-1-expressing intestinal macrophages crucially amplify chronic inflamma-tion in experimental colitis and inflammatory bowel diseases[J]. J Clin Invest, 2007, 117(10):3097-3106.
|
| [13] |
Zhou J, Chai F, Lu G, et al.TREM-1 inhibition attenuates inflammation and tumor within the colon[J]. Int Immuno-pharmacol, 2013, 17(2):155-161.
|
| [14] |
Kim SK, Kim SY, Kim JH, et al.A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients[J]. Mol Oncol, 2014, 8(8):1653-1666.
|
| [15] |
Genua M, Monico MC, D’Alessio S, et al. DOP008 the ab-sence of the triggering receptor expressed on myeloid cells type-2 (TREM-2) induces a transmissible and protective intestinal microbiota for colitis and colitis associated can-cer[J]. J Crohn Colitis, 2014, 8:S18.
|
| [16] |
Genua M, Monico MC, D'Alessio S, et al. 149 intestinal microbiota defined by the absence of the triggering receptor expressed on myeloid cells type-2 (TREM-2) is transmissible and protects from colitis associated cancer[J]. Gastroentero-logy, 2014, 146(5):S42.
|
| [17] |
Vasaturo A, Verweij D, Heinzerling L, et al.Immune in-filtrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients[J]. J Transl Med, 2015, 13(S1):12.
|
| [18] |
Nguyen AH, Koenck C, Quirk SK, et al.Triggering recep-tor expressed on myeloid cells in cutaneous melanoma[J]. Clin Transl Sci, 2015, 8(5):441-444.
|
| [19] |
Kim EJ, Choi MR, Park H, et al.Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary car-cinoma cells and mortality in obesity-resistant BALB/c mice[J]. Breast Cancer Res, 2011, 13(4):1-13.
|
| [20] |
Roberto A, Fabiola G, Alejandro B, et al.Expression of TREM-1 in patients with invasive cervical cancer and pre-cursor lesions[J]. Rev Med Inst Mex Seguro Soc, 2015, 53(6):722-727.
|
| [21] |
Li H, Li W, Yi X, et al.Differential expression of TREM-1 in myelogenous leukemia cells[J]. Blood, 2013, 122(21):4951.
|
| [22] |
Tessarz AS, Cerwenka A.The TREM-1/DAP12 pathway[J]. Immunol Lett, 2008, 116(2):111-116.
|
| [23] |
Bouchon A, Dietrich J, Colonna M.Cutting edge: inflamma-tory responses can be triggered by TREM-1, a novel recep-tor expressed on neutrophils and monocytes[J]. J Immunol, 2000, 164(10):4991-4995.
|
| [24] |
Hara H, Ishihara C, Takeuchi A, et al.The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors[J]. Nat Immunol, 2007, 8(6):619-629.
|
| [25] |
Yao L, Jermanus C, Barbetta B, et al.Porphyromonas gin-givalis infection sequesters pro-apoptotic Bad through Akt in primary gingival epithelial cells[J]. Mol Oral Microbiol, 2010, 25(2):89-101.
|
| [26] |
Volná P, Lebduska P, Dráberová L, et al.Negative regula-tion of mast cell signaling and function by the adaptor LAB/NTAL[J]. J Exp Med, 2004, 200(8):1001-1013.
|
| [27] |
Schneider T, Hoffmann H, Dienemann H, et al.Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3[J]. J Thorac Oncol, 2011, 6(7):1162-1168.
|
| [28] |
Hamerman JA, Jarjoura JR, Humphrey MB, et al.Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12[J]. J Immunol, 2006, 177(4):2051-2055.
|
| [29] |
Ito H, Hamerman JA.TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells[J]. Eur J Immunol, 2012, 42(1):176-185.
|
| [30] |
Perrot I, Blanchard D, Freymond N, et al.Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage[J]. J Immunol, 2007, 178(5):2763-2769.
|
| [31] |
Javed F, Warnakulasuriya S.Is there a relationship between periodontal disease and oral cancer? A systematic review of currently available evidence[J]. Crit Rev Oncol Hematol, 2016, 97:197-205.
|
| [32] |
Chen SS, Wang K, Zhao J, et al.Increased expression of triggering receptor expressed on myeloid cells 1 and 2 in inflamed human gingiva[J]. J Periodont Res, 2017, 52(3):512-521.
|
| [33] |
Bostanci N, Thurnheer T, Belibasakis GN.Involvement of the TREM-1/DAP12 pathway in the innate immune responses to Porphyromonas gingivalis[J]. Mol Immunol, 2011, 49(1/2):387-394.
|
| [34] |
Bostanci N, Thurnheer T, Aduse-Opoku J, et al.Porphyro-monas gingivalis regulates TREM-1 in human polymorpho-nuclear neutrophils via its gingipains[J]. PLoS ONE, 2013, 8(10):e75784.
|
| [35] |
Ha NH, Park DG, Woo BH, et al.Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs[J]. Cytokine, 2016, 86:64-72.
|
| [36] |
Gholizadeh P, Eslami H, Yousefi M, et al.Role of oral mi-crobiome on oral cancers, a review[J]. Biomed Pharmaco-ther, 2016, 84:552-558.
|
| [37] |
Groeger S, Jarzina F, Mamat U, et al.Induction of B7-H1 receptor by bacterial cells fractions of Porphyromonas gin-givalis on human oral epithelial cells: B7-H1 induction by Porphyromonas gingivalis fractions[J]. Immunobiology, 2017, 222(2):137-147.
|
| [38] |
Zhang SS, Tang J, Yu SY, et al.Expression levels of B7-H3 and TLT-2 in human oral squamous cell carcinoma[J]. Oncol Lett, 2015, 10(2):1063-1068.
|
), 吴武超, 吴亚菲, 赵蕾
